Please review the QC test results indicated by icon below as well as clone information before placing your order.

pPmatLuc1

Luciferase of Pyrocoelia matsumurai firefly with higher luminous intensity.

Distribution information

Please check terms and conditions set forth by the depositor, which are specified in the RIKEN BRC Catalog and/or Web Catalog.

Terms and conditions for distribution

In publishing the research results obtained by use of the BIOLOGICAL RESOURCE, a citation of the literature designated by the DEPOSITOR is requested (Akiyoshi R, Ogoh K, Suzuki H. 2012. Firefly luciferase. Japan patent publication 2012-235756). RECIPIENT must contact the OLYMPUS CORPORATION in the case of application for any patents or commercial use(*) based on the results from the use of the BIOLOGICAL RESOURCE. (*)Commercial use shall include: (1) incorporation of the BIOLOGICAL RESOURCE into products for sale; (2) the use of to the BIOLOGICAL RESOURCE for screening candidate compounds; (3) the use of to the BIOLOGICAL RESOURCE for quality control. The RECIPIENT of any organization including for-profit or nonprofit organizations may intend to use the BIOLOGICAL RESOURCE for basic researches with such purposes.

Ordering

Order form [Credit Card Payment]  [Bank Transfer Payment] MTA, for use for not-for-profit academic purpose [Word] MTA, for use for for-profit purpose [Word] Please visit Information of Request for Distribution.[link]

提供案内 (日本国内) [open/close]

提供条件	利用者は、研究成果の公表にあたって別紙に定める寄託者の指定する文献を引用する (ホタル由来ルシフェラーゼ　特開2012-235756)。利用者が本件リソースを使用して得られた研究成果に基づき特許等の申請、及び商業活動(*)を行う場合は、オリンパス株式会社と別途協議を行う。(*)商用活動とは，本件リソースが製品の一部に組み込まれる場合，本件リソースを利用して製品となる候補物を探索または製品の品質管理を行う場合等とする。そのための基礎検討の使用に関しては，営利，非営利機関等の利用者制限は定めない。
提供依頼	提供依頼書 [Word] 提供同意書 (MTA, 非営利学術目的用)[Word] 提供同意書 (MTA, 営利目的用)[Word] 手続きの概要は、「提供申込みについて[link]」をご覧ください。

Please review the QC test results indicated by icon below as well as clone information before placing your order.

How to cite this biological resource

Materials & Methods section:

Reference section:

Further references such as user reports and related articles (go to bottom)

Tips

Featured content

QC test results

RIKEN BRC has sequenced portions of this material for quality test.
Please review the QC test results indicated by icon as well as clone information before placing your order.

Test sheet	RDB14359_A6Jcp1.pdf

Nucleotide sequence of a portion of this resource (if available).

Primer: Reverse2 Sequence file: RDB14359_A6Jca.seq
>D03707A1_A6Jc_2_Reverse2_B04_04_ABI24.ab1     1 CATCATCATT ACGCCAGCTT GCATGCCTGC AGGTCGACTC TAGAGGATCC ACCATGGAAG    61 ATGACCACAA GAACATCGTG CACGGCCCTG CCCCATTCTA CCCCCTGGAA GAGGGAACAG   121 CCGGCGAGCA GCTGCACCGG GCCATGAAGA GATATGCCCA GGTGCCCGGC ACAATCGCCT   181 TCACCGATGC CCACGTGGAA GTGAACATCA CCTACAGCGA GTACTTCGAG ATGGCCTGCC   241 GGCTGGCCGA GACAATGAAG CGCTATGGCC TGGGCCTGCA GCACCACATT GCCGTGTGCA   301 GCGAGAACAG CCTGCAGTTC TTCATGCCCG TGTGTGGCGC CCTGTTCATC GGAGTGGGAG   361 TGGCCCCCAC CAACGACATC TACAACGAGA GAGAGCTGTA CAACAGCCTG AGCATCAGCC   421 AGCCCACCAT CGTGTTCTGC AGCAAGCGGG CCCTGCAGAA AATCCTGGGC GTGCAGAAAA   481 AGCTGCCCGT GATCGAGAAG ATCGTGATCC TGGACAGCCG CGAGGACTAC ATGGGCAAGC   541 AGAGCATGTA CAGCTTCATC GAGAGCCATC TGCCCGCTGG CTTCAACGAG TACGACTACG   601 TGCCCGACAC CTTCGACAGA GAGACAGCCA CCGCCCTGAT CATGAACAGC AGCGGCTCTA   661 CCGGCCTGCC CAAGGGCGTG GAACTGACCC ACAAGAATGT GTGCGTGCGG TTCAGCCACT   721 GCCGGGACCC TGTGTTCGGC AACCAGATCA TCCCCGACAC CGCTATCCTG ACCGTGATCC   781 CCTTCCACCA CGGCTTCGGC ATGTTCACCA CCCTGGGCTA CCTGACCTGC GGCTTCCGGA   841 TCGTGCTGAT GTACAGATTC GAGGAAGAAC TGTTCCTGCG GAGCCTGCAG GACTACAAGA   901 TCCAGAGCGC CCTGCTGGTG CCTACCCTGT TCAGCTTCTT CGCCAAGAGC ACCCTGGTGG   961 ATAAGTACGA CCTGAGCAAC CCTGCACGAG ATCGCCTCTG GGCGGAGCCC CCCCCTGGCT  1021 AAGGAAGGTG GGAGAGCCCG TTGGTCAGCC GGATTCAAGC TGCCGTGGCA TCAGAACAGG 1081 ACTTACGTCT TGACCGAAGC ACAACCCGTC G //
Primer: pUC-M13_-100 Sequence file: RDB14359_A6Jcb.seq
>D03707A1_A6Jc_2_pUC-M13_-100_A04_01_ABI24.ab1     1 GGCCTGTCAG GCCGATTAGT TGGGTACGCC AGGGTTTTCC CAGTCACGAC GTTGTAAAAC    61 GACGGCCAGT GAATTCTCAC AGCTTGCTTT TCTTGCCCAT TGTCAGCATC TCGCGGATCT   121 TCCGGCTGTC GATCTTGCCT GTCAGGCCCT TTGGCACCTC GTCCACGAAC TTCACGCCGC   181 CTCTCAGCCT CTTGCTGGCG GTCACTTGTC CGGCCACGTA GTCCATCACT TCCTGCTCGG   241 TCATGGTCTT GCCCTCTTCC AGCACCACCA CAGCGGCAGG CAGTTCGCCA GCATCAGCAT   301 CAGGGATGCC GGCCACCCCG GCATCGAAGA TGAAGGGATG CTGCAGCAGG ATAGATTCCA   361 GCTCGGCGGG TGGCACCTGG TAGCCCTGGT ACTTGATCAG GGACTTCAGC CGGTCCACGA   421 TGAAGAAGTG GCCGTCCTTG TCGTAGTAGG CCAGGTCGCC AGAGTGCAGC CAGCCATCCT   481 TGTCGATCAG GGCATTGGTG GCCTCGGGGT TGTTCACGTA GCCCTTCATA ATCATGGGGC   541 CCTTCAGACA CAGCTCGCCC CTCTGGTTCA CGCCCAGTGT CTTGCTGGTG TCCAGGTCCA   601 CAATCTTGGC GCTGAAAAAT GGGGCCACCT TTCCACAGGC GCCAGGCTTA TCGTCGCCCC   661 TGGGGGTGAT GATCACGGCA GAGGTTGTCT CGGTCAGGCC GTAGCCCTGT CTGATGCCAG   721 GCAGCTTGAA CCGCTTGGCC ACGGCCTCTC CCACTTCTTT AGCCAGGGGG GCTCCGCCAG   781 AGGCGATCTC GTGCAGGTTG CTCAGGTCGT ACTTATCCAC CAGGGTGCTC TTGGCGAAGA   841 AGCTGAACAG GGTAGGCACC AGCAGGGCGC TCTGGATCTT GTAGTCCTGC AGGCTCCGCA   901 GGAACAGTTC TTCCTCGAAT CTGTACATCA GCACGATCCG GAAGCCGCAG TCAAGGTAGC   961 CCAGGTGGTG AACATGCCGA AGCCGTGGGT GGAATGGGGA TCACGGGTCC AGGAATAGCG  1021 GTGTCGGGGA TGATCTGGGA TTGCCGACAC ACGGTCCCGG CAGTGACCTG ATCGCACGCC 1081 ACAACATTCT TTGTTGGGTT CAAGT //

Please visit Sequencing and PCR primers for primer information.

References

Original, user report and related articles

2024.04.04

HTML_filter_RDB_240329.pl